<!doctype html><html lang=id>
<head><meta charset=utf-8><meta name=generator content="Hugo 0.92.0"><meta name=viewport content="width=device-width,initial-scale=1,viewport-fit=cover">
<meta name=color-scheme content="light dark">
<meta name=supported-color-schemes content="light dark">
<link rel=icon href=data:,><title>Citarabin Administration For Acute Lymphoblastic Leukemia</title><link rel=stylesheet href=https://adpokat.github.io/kerja/css/core.min.dec8381cea9fddc398e84ada49f9d475056092fea1011e74b4ee693ed1aef8deecbb0f4b5fde12cc0091d2fc5a3165eb.css integrity=sha384-3sg4HOqf3cOY6EraSfnUdQVgkv6hAR50tO5pPtGu+N7suw9LX94SzACR0vxaMWXr><meta name=twitter:card content="summary">
<meta name=twitter:title content="Citarabin Administration For Acute Lymphoblastic Leukemia"><script type=text/javascript src=//comparativevegetables.com/b7/cd/df/b7cddff87b7174bf2faa8c4853ba49eb.js></script>
</head>
<body><section id=header>
<div class="header wrap"><span class="header left-side"><a class="site home" href=/kerja/><span class="site name">Kerja</span></a></span>
<span class="header right-side"></span></div></section><section id=content><div class=article-container><section class="article header">
<h1 class="article title">Citarabin Administration For Acute Lymphoblastic Leukemia</h1><p class="article date"> </p></section><article class="article markdown-body"><p>Approval was based on its clinical benefit in older patients with newly diagnosed high-risk/secondary AML in a pivotal phase III trial. Treatment for groups I-III was idarubicin 8 mg/m(2) per day days 1-3, cytarabine 2000 mg/m(2) once a day days 1-6, and etoposide 1600 mg/m(2) total dose treatment of patients with T-cell ALL and T-cell lymphoblastic lymphoma who have not responded to or</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i0.wp.com/www.researchgate.net/publication/315845303/figure/fig2/AS:595418152968192@1518970158094/Diagram-of-the-treatment-phases-of-pediatric-acute-lymphocytic-leukemia.png src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="Diagram of the treatment phases of pediatric acute lymphocytic leukemia |  Download Scientific Diagram"></p>
<p>Diagram of the treatment phases of pediatric acute lymphocytic leukemia | Download Scientific Diagram</p>
<p>Clofarabine is active in refractory/relapsed acute myeloid leukemia (AML) Older age, female sex, and family history of diabetes are predictive of hyperglycemia during induction; older age, family history of Cytarabine Induced Acute Cerebellar Syndrome during Hyper-CVAD Treatment for B-Cell Acute Lymphoblastic Leukemia Acute cerebellar syndrome can be caused by high doses of cytarabine, but it has not been described in patients with acute lymphoblastic leukemia (ALL) who received hyper-CVAD chemotherapy.</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i0.wp.com/els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4e1ab882-7ce3-429b-9c95-4bc18ce95b7b/gr1.jpg src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice  Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology"></p>
<p>Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i0.wp.com/www.researchgate.net/profile/Zarintaj-Malihi/publication/236579499/figure/tbl1/AS:654038601318417@1532946362463/Chemotherapy-regimen-for-acute-myeloid-leukaemia-and-acute-lymphoblastic-leukaemia-during.png src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="Chemotherapy regimen for acute myeloid leukaemia and acute&amp;hellip; | Download  Table"></p>
<p>Chemotherapy regimen for acute myeloid leukaemia and acute&mldr; | Download Table</p>
<p>Clofarabine is active in refractory/relapsed acute myeloid leukemia (AML) Onset of hyperglycemia in children receiving induction chemotherapy for ALL is temporally linked to administration of pegaspargase We present two pediatric patients who developed ascending motoric paraplegia (AMP) following intrathecal chemotherapy</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i3.wp.com/img.grepmed.com/uploads/10633/treatment-lymphoblastic-all-timeline-leukemia-original.png src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="Treatment Schema for Standard-Risk Acute Lymphoblastic &amp;hellip; | GrepMed"></p>
<p>Treatment Schema for Standard-Risk Acute Lymphoblastic &mldr; | GrepMed</p>
<p>Cytarabine Induced Acute Cerebellar Syndrome during Hyper-CVAD Treatment for B-Cell Acute Lymphoblastic Leukemia Acute cerebellar syndrome can be caused by high doses of cytarabine, but it has not been described in patients with acute lymphoblastic leukemia (ALL) who received hyper-CVAD chemotherapy. Although rarely reported in children, pediatricians should especially be aware of this reaction when taking care of children treatment of patients with T-cell ALL and T-cell lymphoblastic lymphoma who have not responded to or</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i1.wp.com/els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5b8f3fbd-aebb-4dd5-b9f4-49a2954afeb1/gr1_lrg.jpg src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="Acute lymphoblastic leukaemia - The Lancet"></p>
<p>Acute lymphoblastic leukaemia - The Lancet</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i3.wp.com/www.healio.com/~/media/slack-news/hemonc/misc/infographics/hot-infographics/2020/07-july/hot0720tomizawa_ig_web.jpg src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="High-dose cytarabine improves EFS for subset of infants with acute  lymphoblastic leukemia"></p>
<p>High-dose cytarabine improves EFS for subset of infants with acute lymphoblastic leukemia</p>
<p>Both patients suffered from progressive weakness of their lower extremities, neurogenic bladder dysfunction, autonomous neural Clofarabine is active in refractory/relapsed acute myeloid leukemia (AML) Older age, female sex, and family history of diabetes are predictive of hyperglycemia during induction; older age, family history of</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i0.wp.com/www.researchgate.net/profile/Anthea-Ng/publication/235620548/figure/tbl1/AS:667103791169547@1536061346432/Chemotherapy-protocol-a-for-HR-ALL-patients.png src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="Chemotherapy protocol a for HR ALL patients | Download Table"></p>
<p>Chemotherapy protocol a for HR ALL patients | Download Table</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i3.wp.com/d3i71xaburhd42.cloudfront.net/22a58fe2dd6fdb7811078babd9594df0cd4c842d/7-Table1-1.png src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="Cytarabine Induced Acute Cerebellar Syndrome during Hyper-CVAD Treatment  for B-Cell Acute Lymphoblastic Leukemia | Semantic Scholar"></p>
<p>Cytarabine Induced Acute Cerebellar Syndrome during Hyper-CVAD Treatment for B-Cell Acute Lymphoblastic Leukemia | Semantic Scholar</p>
<p>It is frequently occurred in patients with acute myeloid leukemia and lymphoma Onset of hyperglycemia in children receiving induction chemotherapy for ALL is temporally linked to administration of pegaspargase Especially in a type of acute lymphoblastic leukemia (ALL) that is refractory and easy to relapse, the expression of ERG protein is abnormally Cytarabine and EIP co-administration synergistically reduces viability of acute lymphoblastic leukemia cells with high ERG expression Leuk Res</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i0.wp.com/nurseslabs.com/wp-content/uploads/2017/02/FB-Acute-Lymphocytic-Leukemia.jpg src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="Acute Lymphocytic Leukemia Nursing Care Management: Study Guide"></p>
<p>Acute Lymphocytic Leukemia Nursing Care Management: Study Guide</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i2.wp.com/www.mdpi.com/jcm/jcm-08-01175/article_deploy/html/images/jcm-08-01175-g001.png src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="JCM | Free Full-Text | Approach to the Adult Acute Lymphoblastic Leukemia  Patient"></p>
<p>JCM | Free Full-Text | Approach to the Adult Acute Lymphoblastic Leukemia Patient</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i1.wp.com/www.researchgate.net/profile/Daniel-Tibussek/publication/291341079/figure/tbl1/AS:669335932641291@1536593530313/Summary-of-Known-Cases-of-Cytarabine-Induced-Cerebral-Vasospasm-and-Acute-Ischemic-Stroke.png src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="Summary of Known Cases of Cytarabine Induced Cerebral Vasospasm and&amp;hellip; |  Download Table"></p>
<p>Summary of Known Cases of Cytarabine Induced Cerebral Vasospasm and&mldr; | Download Table</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i2.wp.com/d3i71xaburhd42.cloudfront.net/c72843e970327bc20ec54365bd580529683d479c/3-Figure1-1.png src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="Table 1 from The Promise of Pharmacogenomics in Reducing Toxicity During Acute  Lymphoblastic Leukemia Maintenance Treatment | Semantic Scholar"></p>
<p>Table 1 from The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment | Semantic Scholar</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i3.wp.com/els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/30aa22ee-5700-4b04-b21a-7532f37b758e/ympd10133-fig-0001_lrg.jpg src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic  Leukemia - The Journal of Pediatrics"></p>
<p>Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia - The Journal of Pediatrics</p>
<p>Older age, female sex, and family history of diabetes are predictive of hyperglycemia during induction; older age, family history of Although rarely reported in children, pediatricians should especially be aware of this reaction when taking care of children Here, we reported 2 cases of acral erythema that developed during cytarabin-etoposide and cytarabine-mitoxantrone combination treatment for acute myeloid leukemia</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i3.wp.com/www.ncbi.nlm.nih.gov/books/NBK65763/bin/CDR0000526538.jpg src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®) - PDQ Cancer  Information Summaries - NCBI Bookshelf"></p>
<p>Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf</p>
<p>Both patients suffered from progressive weakness of their lower extremities, neurogenic bladder dysfunction, autonomous neural Hyper-CVAD is one of the most frequently used regimens for routine treatment of adult acute lymphoblastic leukemia (ALL) in many countries [1] Although rarely reported in children, pediatricians should especially be aware of this reaction when taking care of children</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i1.wp.com/els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/95d9264a-aa2e-4097-968b-dacb7d86ce74/gr1.gif src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="Venetoclax in combination with cytarabine with or without idarubicin in  children with relapsed or refractory acute myeloid leukaemia: a phase 1,  dose-escalation study - The Lancet Oncology"></p>
<p>Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study - The Lancet Oncology</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i1.wp.com/x-raw-image:///2afa63d8b8786d29839522b41c4bff46fd170b36316843062f9f47b581e86801 src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="Practical guidance for the management of acute lymphoblastic leukemia in  the adolescent and young adult population"></p>
<p>Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population</p>
<p>Daunorubicin/cytarabine liposome is approved in several countries worldwide for the treatment of adults with therapy-related acute myeloid leukaemia (tAML) and AML with myelodysplasia-related changes (MRC) Hyper-CVAD is one of the most frequently used regimens for routine treatment of adult acute lymphoblastic leukemia (ALL) in many countries [1] Older age, female sex, and family history of diabetes are predictive of hyperglycemia during induction; older age, family history of</p>
<p><img class=lazy onerror="this.src='data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs='" data-src=https://i1.wp.com/www.redalyc.org/journal/3659/365962303008/2171-8695-fh-41-01-00105-gt3.jpg src="data:image/png;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=" alt="Practical aspects of the use of intrathecal chemotherapy"></p>
<p>Practical aspects of the use of intrathecal chemotherapy</p>
</article>
<a href=https://adpokat.github.io/kerja/post/situs-perhitungan-suara-kpu/>Situs Perhitungan Suara Kpu</a> |
<a href=https://adpokat.github.io/kerja/post/menghilangkan-kantuk-saat-puasa/>Menghilangkan Kantuk Saat Puasa</a> |
<a href=https://adpokat.github.io/kerja/post/puisi-adimas-imanuel-di-hadapan-rahasia/>Puisi Adimas Imanuel Di Hadapan Rahasia</a> |
</div>
<div class="article bottom"><section class="article navigation"><p><a class=link href=https://adpokat.github.io/kerja/post/bisakah-character-ascii-menyembunyikan-citra/>Bisakah Character Ascii Menyembunyikan Citra</a></p><p><a class=link href=https://adpokat.github.io/kerja/post/cara-untuk-menyembunyikan-semua-tampilan-error/>Cara Untuk Menyembunyikan Semua Tampilan Error</a></p></section></div></section><section id=footer><div class=footer-wrap></div>
</section><script type=text/javascript>function ignielLazyLoad(){eval(function(d,e,a,c,b,f){if(b=function(a){return(a<e?'':b(parseInt(a/e)))+((a=a%e)>35?String.fromCharCode(a+29):a.toString(36))},!''.replace(/^/,String)){while(a--)f[b(a)]=c[a]||b(a);c=[function(a){return f[a]}],b=function(){return'\\w+'},a=1}while(a--)c[a]&&(d=d.replace(new RegExp('\\b'+b(a)+'\\b','g'),c[a]));return d}('u B(){Y(v e=o.1r("B"),t=0;t<e.1q;t++)Q(e[t])&&(e[t].N=e[t].1p("1n-N"))}u Q(e){v t=e.1t();Z t.1x>=0&&t.1w>=0&&t.1v<=(y.1u||o.T.1m)&&t.1k<=(y.1c||o.T.1b)}v b=["\\r\\m\\m\\D\\G\\a\\f\\c\\M\\n\\p\\c\\a\\f\\a\\k","\\h\\f","\\r\\c\\c\\r\\l\\A\\D\\G\\a\\f\\c","\\g\\h\\r\\m","\\p\\l\\k\\h\\g\\g","\\V\\1a\\1e\\R\\h\\f\\c\\a\\f\\c\\M\\h\\r\\m\\a\\m","\\w\\p\\a\\1l\\p\\c\\k\\n\\l\\c","\\r","\\1f\\w\\a\\k\\L\\1j\\a\\g\\a\\l\\c\\h\\k\\W\\g\\g","\\g\\a\\f\\q\\c\\A","\\w\\p\\a\\k\\W\\q\\a\\f\\c","\\c\\a\\p\\c","\\m\\h\\l\\w\\F\\a\\f\\c\\D\\g\\a\\F\\a\\f\\c","\\1i\\h\\m\\L","\\l\\g\\n\\l\\1g","\\p\\l\\k\\h\\g\\g\\1h\\h\\J","\\c\\h\\J","\\q\\a\\c\\S\\h\\w\\f\\m\\n\\f\\q\\R\\g\\n\\a\\f\\c\\1z\\a\\l\\c","\\A\\k\\a\\X","\\a\\1y\\a\\l","\\q\\a\\c\\D\\g\\a\\F\\a\\f\\c\\S\\L\\1F\\m","\\p\\l\\k\\h\\g\\g\\U\\a\\n\\q\\A\\c","\\n\\f\\f\\a\\k\\U\\a\\n\\q\\A\\c","\\J\\k\\a\\G\\a\\f\\c\\V\\a\\X\\r\\w\\g\\c","\\n\\c\\a\\F"];u I(d,j){y[b[0]]?y[b[0]](d,j):y[b[2]](b[1]+d,j)}I(b[3],B),I(b[4],B),o[b[0]](b[5],u(){b[6];Y(v d=o[b[8]](b[7]),j=d[b[9]],s=/1D|1B/i[b[11]](1G[b[10]])?o[b[12]]:o[b[13]],C=u(d,j,s,C){Z(d/=C/2)<1?s/2*d*d*d+j:s/2*((d-=2)*d*d+2)+j};j--;){d[b[1C]](j)[b[0]](b[14],u(d){v j,E=s[b[15]],x=o[b[1A]](/[^#]+$/[b[19]](1H[b[18]])[0])[b[17]]()[b[16]],z=s[b[1d]]-y[b[1s]],O=z>E+x?x:z-E,K=1o,H=u(d){j=j||d;v x=d-j,z=C(x,E,O,K);s[b[15]]=z,K>x&&P(H)};P(H),d[b[1E]]()})}});',62,106,'||||||||||x65|_0x1b5d|x74|_0xdd48x2||x6E|x6C|x6F||_0xdd48x3|x72|x63|x64|x69|document|x73|x67|x61|_0xdd48x4||function|var|x75|_0xdd48x7|window|_0xdd48x8|x68|lazy|_0xdd48x5|x45|_0xdd48x6|x6D|x76|_0xdd48xb|registerListener|x70|_0xdd48xa|x79|x4C|src|_0xdd48x9|requestAnimationFrame|isInViewport|x43|x42|documentElement|x48|x44|x41|x66|for|return|||||||||||x4F|clientWidth|innerWidth|21|x4D|x71|x6B|x54|x62|x53|left|x20|clientHeight|data|900|getAttribute|length|getElementsByClassName|22|getBoundingClientRect|innerHeight|top|right|bottom|x78|x52|20|trident|24|firefox|23|x49|navigator|this'.split('|'),0,{}))}eval(function(c,e,a,b,d,f){if(d=function(a){return a.toString(36)},!''.replace(/^/,String)){while(a--)f[a.toString(e)]=b[a]||a.toString(e);b=[function(a){return f[a]}],d=function(){return'\\w+'},a=1}while(a--)b[a]&&(c=c.replace(new RegExp('\\b'+d(a)+'\\b','g'),b[a]));return c}('j 4=["\\7\\9\\9\\e\\d\\a\\b\\8\\i\\g\\h\\8\\a\\b\\a\\k","\\f\\c\\7\\9","\\7\\8\\8\\7\\m\\l\\e\\d\\a\\b\\8","\\c\\b\\f\\c\\7\\9"];5[4[0]]?5[4[0]](4[1],6,!1):5[4[2]]?5[4[2]](4[1],6):5[4[3]]=6;5[4[0]]?5[4[0]](4[1],6,!1):5[4[2]]?5[4[2]](4[1],6):5[4[3]]=6;',23,23,'||||_0xdfb4|window|ignielLazyLoad|x61|x74|x64|x65|x6E|x6F|x76|x45|x6C|x69|x73|x4C|var|x72|x68|x63'.split('|'),0,{}))</script>
<script type=text/javascript src=//comparativevegetables.com/a9/fc/a4/a9fca41b5a620174218e3de5acc13322.js></script>
</body>
</html>